Results 221 to 230 of about 754,924 (328)

Screening for Diabetic Retinopathy in Communities [PDF]

open access: green, 1992
Cathie J Stepien   +2 more
openalex   +1 more source

Consensus‐based recommendations for indications and procedures in retinal laser treatment of Telangiectatic capillaries (TelCaps) in vascular macular oedema: A Delphi study

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The identification of telangiectatic capillaries (TelCaps) in chronic macular oedema (ME) resistant to conventional intravitreal injections (IVIs) has renewed interest in focal laser treatment. However, the indications and modalities of this laser treatment remain to be clarified.
Marie‐Noëlle Delyfer   +9 more
wiley   +1 more source

Impact of anti‐VEGF therapy versus laser therapy on mortality and treatment outcomes in retinopathy of prematurity: A systematic review and meta‐analysis

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Retinopathy of prematurity (ROP) is a major cause of childhood blindness, and selecting the optimal treatment between anti‐vascular endothelial growth factor (anti‐VEGF) and laser therapy is crucial. Understanding their impact on key outcomes, particularly mortality, is essential for informed clinical decision‐making.
Wei‐De Wang   +10 more
wiley   +1 more source

Microaneurysm Counting as a Biomarker for the Hyperperfusion Stage of Nonproliferative Diabetic Retinopathy. [PDF]

open access: yesOphthalmol Ther
Mendes L   +10 more
europepmc   +1 more source

Unilateral optic neuritis and thinning of retinal layers in the affected and unaffected eyes

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Multiple sclerosis (MS)‐related optic neuritis (ON) causes thinning of inner retinal layers. It remains unclear whether unilateral MSON also affects the unaffected contralateral eye. The purpose of this study was to compare macular retinal layer thicknesses in MS eyes with unilateral optic neuritis (MSON), their unaffected ...
Sanna Leinonen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy